Business Context and Reporting Period
Company: Northern Technologies International Corp (NTIC)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: May 31, 2009 (Nine months ended May 31, 2009)
Business Overview: NTIC develops and markets proprietary environmentally beneficial products, primarily corrosion prevention (ZERUST®), bio-plastics (Natur-Tec®), and plastic-to-fuel conversion technology. The company operates through direct sales in North America and a network of 29 corporate joint ventures globally.
Key Financial Metrics
| Metric | Nine Months Ended May 31, 2009 | Nine Months Ended May 31, 2008 |
|---|---|---|
| Net Sales (North American) | $6,678,748 | $9,518,162 |
| Net (Loss) Income | $(2,139,484) | $2,106,034 |
| Net (Loss) Income Per Share (Diluted) | $(0.57) | $0.56 |
| Gross Profit | $2,234,673 | $3,754,662 |
| Operating Cash Flow | $(1,561,467) | $(1,595,955) |
| Cash and Cash Equivalents | $141,639 | $260,460 (Aug 31, 2008) |
| Working Capital | $4,915,140 | $4,941,371 (Aug 31, 2008) |
| Debt (Line of Credit Borrowings) | $963,000 | $86,000 (Aug 31, 2008) |
| Total Debt (Line of Credit + Note Payable) | $2,150,521 | $1,267,528 (Aug 31, 2008) |
Material Changes vs. Prior Period
- Revenue Decline: North American net sales decreased 29.8% year-over-year, driven by a 31.7% drop in ZERUST® sales due to the global economic recession and the automotive industry downturn. React Inc. sales dropped 100% as the primary customer ceased orders.
- Profitability Reversal: The company swung from a net income of $2.1 million in the prior year to a net loss of $2.1 million. This was primarily caused by reduced sales volume and a one-time impairment charge.
- Impairment Charge: A non-cash loss on impairment of goodwill and intangible assets of $554,000 was recorded related to the React-NTI reporting unit, as its fair value fell below carrying value.
- Joint Venture Performance: Equity in income from corporate joint ventures decreased 78.4% to $650,900, reflecting a 41.6% decline in total joint venture sales.
- Cost Reductions: Operating expenses were reduced through salary cuts (15% for executives, 10% for others), a hiring freeze, and a 16% workforce reduction. Selling expenses decreased 20.3% and G&A expenses decreased 14.2%.
- Liquidity Position: Cash reserves decreased by $118,821. Borrowings under the $2.3 million line of credit increased significantly to $963,000 to support operations.
Guidance, Outlook, and Risks
- Outlook: Management expects the automotive industry downturn to persist in the short-to-medium term. However, they anticipate Natur-Tec® sales will increase in the fourth fiscal quarter due to a significant customer resuming purchases.
- R&D Investment: NTIC anticipates spending between $2.8 million and $3.0 million on R&D for the full fiscal year 2009, focusing on emerging businesses (bio-plastics, oil/gas corrosion tech, plastic-to-fuel).
- Liquidity Strategy: The company expects to meet liquidity requirements for the next 12 months using existing cash, operating cash flows, joint venture distributions, and its line of credit. Additional financing (debt or equity) may be sought to fund new market opportunities.
- Key Risks:
- Dependence on the global automotive industry and economic conditions.
- Reliance on joint ventures for revenue and dividends; NTIC does not control dividend decisions.
- Foreign currency exchange rate fluctuations affecting reported income.
- Unresolved litigation with Shamrock Technologies, Inc. (mediation at an impasse).
Investor Verification Checklist
- Joint Venture Solvency: Verify the financial health of the 29 corporate joint ventures, as they represent a significant portion of NTIC's revenue stream and equity income.
- Automotive Exposure: Assess the extent of NTIC's exposure to the automotive sector and the timeline for recovery in that specific market.
- Debt Covenants: Review the terms of the $2.3 million demand line of credit with National City Bank to ensure no covenant breaches exist given the current loss position.
- React-NTI Status: Confirm the status of the React-NTI subsidiary, which has been impaired to near zero book value, and whether it remains a drain on resources.
- Natur-Tec Growth: Validate the projected sales increase for Natur-Tec® products in the fourth quarter to ensure it offsets the decline in core ZERUST® sales.